Skip to the page

Data / Drug companies / Morphine sulfate

Morphine sulfate: 31 companies and 150 products in the FDA NDC directory

Morphine sulfate is listed in the FDA National Drug Code Directory by 31 companies, with 150 products in commercial distribution. 107 of the products (71.3%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated, extended release; solution; capsule, extended release, and the newest product started marketing on July 30, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
31
Products
150
Generic (ANDA) products
107 (71.3%)
Application numbers
29
Controlled substance schedule
Schedule II
Routes
Oral, Intravenous, Intramuscular, Rectal, Epidural
Brand names
MS Contin, Mitigo, Duramorph, Infumorph 200, Infumorph 500
openFDA record search
api.fda.gov

Companies that list morphine sulfate

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Bryant Ranch Prepack14tablet, film coated, extended release; suppositoryGeneric drugs (ANDA)February 11, 2021
Hikma Pharmaceuticals USA Inc.9injection; injection, solutionGeneric drugs (ANDA)April 18, 2025
Upsher-Smith Laboratories, LLC9capsule, extended release; tabletGeneric drugs (ANDA)July 22, 2019
Rhodes Pharmaceuticals LLC8tablet, film coated, extended releaseGeneric drugs (ANDA)May 15, 2017
SpecGx LLC8tablet, extended release; tabletGeneric drugs (ANDA)September 1, 2023
Amneal Pharmaceuticals of New York LLC7capsule, extended releaseGeneric drugs (ANDA)October 5, 2018
Bryant Ranch Prepack7tablet, film coated, extended release; solutionGeneric drugs (ANDA)September 21, 2015
Actavis Pharma, Inc.6capsule, extended releaseGeneric drugs (ANDA)February 4, 2014
Fresenius Kabi USA, LLC6injection, solutionNew drug applications (NDA)October 30, 2013
Hospira, Inc.6injection, solutionNew drug applications (NDA)April 21, 2025
Nortec Development Associates, Inc.6capsule, extended releaseGeneric drugs (ANDA)April 7, 2009
Precision Dose, Inc.6solutionNew drug applications (NDA)September 1, 2025
American Health Packaging5solutionGeneric drugs (ANDA)May 1, 2026
Bryant Ranch Prepack5tablet, film coated, extended release; tabletGeneric drugs (ANDA)February 11, 2021
Fresenius Kabi USA, LLC5injection, solutionNew drug applications (NDA)April 10, 2018
Hikma Pharmaceuticals USA Inc.5solution; tabletNew drug applications (NDA)March 17, 2008
Lupin Pharmaceuticals,Inc.5tablet, film coated, extended releaseGeneric drugs (ANDA)December 16, 2015
Sun Pharmaceutical Industries, Inc.5tablet, film coated, extended releaseGeneric drugs (ANDA)May 11, 2012
Major Pharmaceuticals4tablet, film coated, extended releaseGeneric drugs (ANDA)January 14, 2011
Padagis US LLC4suppositoryOther unapproved drugsSeptember 1, 1990
American Health Packaging3solution; tabletGeneric drugs (ANDA)February 1, 2026
Winder Laboratories LLC3solutionGeneric drugs (ANDA)May 15, 2019
American Health Packaging2tablet, film coated, extended releaseGeneric drugs (ANDA)November 5, 2013
Ascend Laboratories, LLC2tabletGeneric drugs (ANDA)February 11, 2021
Pai Holdings, LLC DBA Pai Pharma2solutionGeneric drugs (ANDA)September 15, 2025
Piramal Critical Care Inc2injectionGeneric drugs (ANDA)February 25, 2019
Redpharm Drug2tabletGeneric drugs (ANDA)September 1, 2023
Civica, Inc.1injectionGeneric drugs (ANDA)November 11, 2019
Cranbury Pharmaceuticals, LLC1solutionGeneric drugs (ANDA)September 21, 2015
International Medication Systems, Limited1injectionGeneric drugs (ANDA)January 20, 2022
St. Mary's Medical Park Pharmacy1tabletGeneric drugs (ANDA)July 30, 2026

Dosage forms

Dosage formProductsShare
Tablet, film coated, extended release4127.3%
Solution2617.3%
Capsule, extended release2617.3%
Injection, solution1912.7%
Tablet149.3%
Injection117.3%
Suppository85.3%
Tablet, extended release53.3%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)10771.3%
New drug applications (NDA)3523.3%
Other unapproved drugs85.3%

Pharmacologic classes

ClassProducts
Opioid Agonist150

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.